Home Semiconductor & Electronics Electronic Components Ankylosing Spondylitis Market

Ankylosing Spondylitis Market Size, Share & Trends Analysis Report By Drug Class (Non-Steroidal Anti-Inflammatory Drug (NSAID), Other Drug Classes), By Disease Stage (Early-Stage Ankylosing Spondylitis, Moderate Ankylosing Spondylitis, Severe / Advanced Ankylosing Spondylitis), By Diagnostic Method (MRI, X-Ray Radiography, Blood Biomarkers (CRP/ESR), HLA-B27 Genetic Testing, Digital Spine Monitoring Tools), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Ankylosing Spondylitis Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
      1. TNF Inhibitors
      2. Humira
      3. Simponi
      4. Remicade
      5. Enbrel
      6. Cimzia
      7. Other TNF Inhibitors
    2. Other Drug Classes
  2. Ankylosing Spondylitis Market, By Disease Stage 2022-2034 (USD MILLION/ Units)
    1. Early-Stage Ankylosing Spondylitis
    2. Moderate Ankylosing Spondylitis
    3. Severe / Advanced Ankylosing Spondylitis
  3. Ankylosing Spondylitis Market, By Diagnostic Method 2022-2034 (USD MILLION/ Units)
    1. MRI
    2. X-Ray Radiography
    3. Blood Biomarkers (CRP/ESR)
    4. HLA-B27 Genetic Testing
    5. Digital Spine Monitoring Tools
  4. Ankylosing Spondylitis Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Others
  5. Regional Ankylosing Spondylitis Market
    1. North America
      1. North America Ankylosing Spondylitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
      2. North America Ankylosing Spondylitis Market By Disease Stage 2022-2034 (USD MILLION/ Units)
        1. Early-Stage Ankylosing Spondylitis
        2. Moderate Ankylosing Spondylitis
        3. Severe / Advanced Ankylosing Spondylitis
      3. North America Ankylosing Spondylitis Market By Diagnostic Method 2022-2034 (USD MILLION/ Units)
        1. MRI
        2. X-Ray Radiography
        3. Blood Biomarkers (CRP/ESR)
        4. HLA-B27 Genetic Testing
        5. Digital Spine Monitoring Tools
      4. North America Ankylosing Spondylitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others
      5. U.S.
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      6. Canada
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
    2. Europe
      1. Europe Ankylosing Spondylitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
      2. Europe Ankylosing Spondylitis Market By Disease Stage 2022-2034 (USD MILLION/ Units)
        1. Early-Stage Ankylosing Spondylitis
        2. Moderate Ankylosing Spondylitis
        3. Severe / Advanced Ankylosing Spondylitis
      3. Europe Ankylosing Spondylitis Market By Diagnostic Method 2022-2034 (USD MILLION/ Units)
        1. MRI
        2. X-Ray Radiography
        3. Blood Biomarkers (CRP/ESR)
        4. HLA-B27 Genetic Testing
        5. Digital Spine Monitoring Tools
      4. Europe Ankylosing Spondylitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others
      5. U.K.
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      6. Germany
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      7. France
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      8. Spain
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      9. Italy
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      10. Russia
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      11. Nordic
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      12. Benelux
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      13. Rest of Europe
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
    3. APAC
      1. APAC Ankylosing Spondylitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
      2. APAC Ankylosing Spondylitis Market By Disease Stage 2022-2034 (USD MILLION/ Units)
        1. Early-Stage Ankylosing Spondylitis
        2. Moderate Ankylosing Spondylitis
        3. Severe / Advanced Ankylosing Spondylitis
      3. APAC Ankylosing Spondylitis Market By Diagnostic Method 2022-2034 (USD MILLION/ Units)
        1. MRI
        2. X-Ray Radiography
        3. Blood Biomarkers (CRP/ESR)
        4. HLA-B27 Genetic Testing
        5. Digital Spine Monitoring Tools
      4. APAC Ankylosing Spondylitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others
      5. China
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      6. Korea
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      7. Japan
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      8. India
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      9. Australia
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      10. Taiwan
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      11. South East Asia
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      12. Rest of Asia-Pacific
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Ankylosing Spondylitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
      2. Middle East and Africa Ankylosing Spondylitis Market By Disease Stage 2022-2034 (USD MILLION/ Units)
        1. Early-Stage Ankylosing Spondylitis
        2. Moderate Ankylosing Spondylitis
        3. Severe / Advanced Ankylosing Spondylitis
      3. Middle East and Africa Ankylosing Spondylitis Market By Diagnostic Method 2022-2034 (USD MILLION/ Units)
        1. MRI
        2. X-Ray Radiography
        3. Blood Biomarkers (CRP/ESR)
        4. HLA-B27 Genetic Testing
        5. Digital Spine Monitoring Tools
      4. Middle East and Africa Ankylosing Spondylitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others
      5. UAE
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      6. Turkey
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      7. Saudi Arabia
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      8. South Africa
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      9. Egypt
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      10. Nigeria
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      11. Rest of MEA
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
    5. LATAM
      1. LATAM Ankylosing Spondylitis Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
      2. LATAM Ankylosing Spondylitis Market By Disease Stage 2022-2034 (USD MILLION/ Units)
        1. Early-Stage Ankylosing Spondylitis
        2. Moderate Ankylosing Spondylitis
        3. Severe / Advanced Ankylosing Spondylitis
      3. LATAM Ankylosing Spondylitis Market By Diagnostic Method 2022-2034 (USD MILLION/ Units)
        1. MRI
        2. X-Ray Radiography
        3. Blood Biomarkers (CRP/ESR)
        4. HLA-B27 Genetic Testing
        5. Digital Spine Monitoring Tools
      4. LATAM Ankylosing Spondylitis Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacy
        2. Retail Pharmacy
        3. Others
      5. Brazil
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      6. Mexico
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      7. Argentina
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      8. Chile
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      9. Colombia
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
      10. Rest of LATAM
        1. Non-Steroidal Anti-Inflammatory Drug (NSAID)
          1. TNF Inhibitors
          2. Humira
          3. Simponi
          4. Remicade
          5. Enbrel
          6. Cimzia
          7. Other TNF Inhibitors
        2. Other Drug Classes
        3. Early-Stage Ankylosing Spondylitis
        4. Moderate Ankylosing Spondylitis
        5. Severe / Advanced Ankylosing Spondylitis
        6. MRI
        7. X-Ray Radiography
        8. Blood Biomarkers (CRP/ESR)
        9. HLA-B27 Genetic Testing
        10. Digital Spine Monitoring Tools
        11. Hospital Pharmacy
        12. Retail Pharmacy
        13. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.